1.13.11.70	(2E)-3-(3,4-dimethoxyphenyl)-N-hydroxyprop-2-enamide	over 95% inhibition at 0.1 mM	219585	
1.13.11.70	(2E)-N-benzyl-N-hydroxy-3,7-dimethylocta-2,6-dienamide	52% inhibition at 0.1 mM	222756	
1.13.11.70	(2E)-N-hydroxy-3-(4-methoxyphenyl)prop-2-enamide	over 95% inhibition at 0.1 mM	219587	
1.13.11.70	(2E,4E)-N-benzyl-N-hydroxy-5,9-dimethyldeca-2,4,8-trienamide	47% inhibition at 0.1 mM	222757	
1.13.11.70	(2E,4E)-N-hydroxy-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienamide	over 95% inhibition at 0.1 mM	222758	
1.13.11.70	2-(2H-1,3-benzodioxol-5-yl)-N-[(4-fluorophenyl)methyl]-N-hydroxyacetamide	over 95% inhibition at 0.1 mM	219583	
1.13.11.70	2-(3,4-dimethoxyphenyl)-N-[(4-fluorophenyl)methyl]-N-hydroxyacetamide	over 95% inhibition at 0.1 mM	223038	
1.13.11.70	3-(3,4-dimethoxyphenyl)-N-hydroxy-N-octylpropanamide	over 95% inhibition at 0.1 mM	220261	
1.13.11.70	3-(3,4-dimethoxyphenyl)-N-hydroxypropanamide	78% inhibition at 0.1 mM	219586	
1.13.11.70	3-amino-N-benzyl-N-hydroxybenzamide	over 95% inhibition at 0.1 mM	223250	
1.13.11.70	abamine	over 95% inhibition at 0.1 mM	151016	
1.13.11.70	additional information	no evidence for feedback regulation	2	
1.13.11.70	additional information	AtCCD8 is inhibited in a time-dependent fashion by hydroxamic acids N-[(4-fluorophenyl)methyl]-N-hydroxy-2-(4-hydroxyphenyl)acetamide, N-[(4-fluorophenyl)methyl]-N-hydroxy-2-(4-methoxyphenyl)acetamide, N-benzyl-2-(3,4-dimethoxyphenyl)-N-hydroxyacetamide and 2-(3,4-dimethoxyphenyl)-N-[(4-fluorophenyl)methyl]-N-hydroxyacetamide with over 95% inhibition at 0.10 mM, hydroxamic acids acids N-[(4-fluorophenyl)methyl]-N-hydroxy-2-(4-hydroxyphenyl)acetamide, N-[(4-fluorophenyl)methyl]-N-hydroxy-2-(4-methoxyphenyl)acetamide, N-benzyl-2-(3,4-dimethoxyphenyl)-N-hydroxyacetamide and 2-(3,4-dimethoxyphenyl)-N-[(4-fluorophenyl)methyl]-N-hydroxyacetamide cause a shoot branching phenotype in Arabidopsis thaliana. Selective inhibition of CCD8 is observed using hydroxamic acids N-hydroxy-3-(4-methoxyphenyl)propanamide and N-[(4-fluorophenyl)methyl]-N-hydroxy-3-(4-methoxyphenyl)propanamide. No inhibition by N1-[(4-fluorophenyl)methyl]-N1-hydroxy-N4-[(4-methoxyphenyl)methyl]butanediamide	2	
1.13.11.70	N-benzyl-2-(3,4-dimethoxyphenyl)-N-hydroxyacetamide	over 95% inhibition at 0.1 mM	223973	
1.13.11.70	N-benzyl-3-chloro-N-hydroxybenzamide	over 95% inhibition at 0.1 mM	223977	
1.13.11.70	N-benzyl-N-hydroxy-2-(4-hydroxyphenyl)acetamide	over 95% inhibition at 0.1 mM	223982	
1.13.11.70	N-benzyl-N-hydroxy-3,4-dimethoxybenzamide	over 95% inhibition at 0.1 mM	223983	
1.13.11.70	N-benzyl-N-hydroxy-3-(4-methoxyphenyl)propanamide	over 95% inhibition at 0.1 mM	223984	
1.13.11.70	N-benzyl-N-hydroxy-4-methoxybenzamide	over 95% inhibition at 0.1 mM	223985	
1.13.11.70	N-hydroxy-3-(4-methoxyphenyl)-N-octylpropanamide	over 95% inhibition at 0.1 mM	223991	
1.13.11.70	N-hydroxy-3-(4-methoxyphenyl)propanamide	over 95% inhibition at 0.1 mM	219588	
1.13.11.70	N-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-N-hydroxy-2-(4-methoxyphenyl)acetamide	70% inhibition at 0.1 mM	224000	
1.13.11.70	N-[(4-fluorophenyl)methyl]-N-hydroxy-2-(4-hydroxyphenyl)acetamide	over 95% inhibition at 0.1 mM	224018	
1.13.11.70	N-[(4-fluorophenyl)methyl]-N-hydroxy-2-(4-methoxyphenyl)acetamide	over 95% inhibition at 0.1 mM	224019	
1.13.11.70	N-[(4-fluorophenyl)methyl]-N-hydroxy-3,4-dimethoxybenzamide	over 95% inhibition at 0.1 mM	224020	
1.13.11.70	N-[(4-fluorophenyl)methyl]-N-hydroxy-3-(4-methoxyphenyl)propanamide	over 95% inhibition at 0.1 mM	224021	
1.13.11.70	N-[(4-fluorophenyl)methyl]-N-hydroxy-4-methoxybenzamide	over 95% inhibition at 0.1 mM	224022	
1.13.11.70	N1-[(4-fluorophenyl)methyl]-N1-hydroxy-N4-[(4-methoxyphenyl)methyl]butanediamide	-	224112	
1.13.11.70	sodium 3-[hydroxy[(4-methoxyphenyl)acetyl]amino]propanoate	47% inhibition at 0.1 mM	224165	
1.13.11.70	sodium 3-[hydroxy[(naphthalen-2-yl)acetyl]amino]propanoate	92% inhibition at 0.1 mM	224166